Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
![PEAR-TREE: Understanding the usefulness of the PEAR-BIO platform in patients with kidney cancer](http://media.springernature.com/w100/bmc-blogs/on-medicine/wp-content/uploads/sites/6/2024/01/2024-01-05-13_37_18-Window-125x125.png)
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
Citation Impact 2023
Journal Impact Factor: 29.5
5-year Journal Impact Factor: 26.9
Source Normalized Impact per Paper (SNIP): 4.489
SCImago Journal Rank (SJR): 7.522
Speed 2023
Submission to first editorial decision (median days): 4
Submission to acceptance (median days): 59
Usage 2023
Downloads: 3,173,795
Altmetric mentions: 2,671
06 April 2023
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).